|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.590 USD | +1.57% |
|
-5.82% | -75.11% |
| 05-18 | ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-10 | ISpecimen Inc. announced that it has received $2.500004 million in funding | CI |
Company Valuation: iSpecimen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 68.07 | 12.26 | 4.543 | 2.556 | 2.541 |
| Change | - | -81.98% | -62.95% | -43.74% | -0.56% |
| Enterprise Value (EV) 1 | 43.75 | -2.86 | -0.2663 | 0.9895 | -4.071 |
| Change | - | -106.54% | 90.69% | 471.55% | -511.4% |
| P/E | - | -1.19x | -0.41x | -0.15x | -0.11x |
| PBR | 2.29x | 0.6x | 0.47x | 1.36x | 0.71x |
| PEG | - | - | -0.07x | 0x | 0x |
| Capitalization / Revenue | 6.11x | 1.18x | 0.46x | 0.28x | 1.32x |
| EV / Revenue | 3.93x | -0.27x | -0.03x | 0.11x | -2.11x |
| EV / EBITDA | -7.44x | 0.28x | 0.02x | -0.08x | 0.47x |
| EV / EBIT | -7.38x | 0.28x | 0.02x | -0.08x | 0.45x |
| EV / FCF | -3.36x | 0.54x | 0.04x | -0.2x | 1.46x |
| FCF Yield | -29.8% | 185% | 2,404% | -494% | 68.4% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | - | -926.8 | -984 | -703.3 | -91.15 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 11.14 | 10.4 | 9.928 | 9.291 | 1.929 |
| EBITDA 1 | -5.88 | -10.16 | -11 | -12.47 | -8.718 |
| EBIT 1 | -5.925 | -10.19 | -11.17 | -12.73 | -8.978 |
| Net income 1 | -8.962 | -10.25 | -11.1 | -12.5 | -10.49 |
| Net Debt 1 | -24.32 | -15.12 | -4.809 | -1.566 | -6.612 |
| Reference price 2 | 6,248.000 | 1,100.000 | 400.480 | 106.200 | 10.404 |
| Nbr of stocks (in thousands) | 10.9 | 11.1 | 11.3 | 24.1 | 244 |
| Announcement Date | 22/03/22 | 21/03/23 | 13/03/24 | 14/04/25 | 01/04/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.72M | |
| 21.88x | 8.41x | 13.98x | 0.97% | 2,818B | |
| 95.24x | 38.43x | 64.23x | -.--% | 308B | |
| 139.58x | 41.52x | 140.49x | 0.13% | 140B | |
| 86.09x | 17.3x | 37.59x | -.--% | 107B | |
| 168.33x | 9.78x | 24.17x | -.--% | 87.22B | |
| 409.3x | 17.2x | 69.27x | -.--% | 79.38B | |
| 30.04x | 1.55x | 12.1x | -.--% | 55.91B | |
| 136.52x | 5.1x | 25.96x | -.--% | 44.43B | |
| -33.85x | 4.54x | 21.75x | -.--% | 36.89B | |
| Average | 117.01x | 15.98x | 45.51x | 0.12% | 367.69B | |
| Weighted average by Cap. | 47.16x | 12.48x | 25.32x | 0.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ISPC Stock
- Valuation iSpecimen Inc.
Select your edition
All financial news and data tailored to specific country editions
